Literature DB >> 10704897

The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with solutol HS 15.

K Buszello1, S Harnisch, R H Müller, B W Müller.   

Abstract

Arachis oil based parenteral O/W emulsions were prepared using soya bean phosphatidylcholine (SPC) and different combinations of co-emulsifiers containing polyethylene glycol fatty acid esters (Solutol HS 15) and alkali fatty acids (sodium laurate, sodium stearate). The parameters measured were droplet size (both by photon correlation spectroscopy and laser diffractometry), pH and zeta potential. All emulsions were subjected to autoclaving. The addition of polyethylene glycol 12-hydroxy stearate (Solutol HS 15) led to a significant decrease of mean oil droplet size. For long-term stability the amount added turned out to be the most important factor. With increased amounts of Solutol HS 15 the packing density of the emulsifier layer and the zeta potential decreased leading to instability. The optimum load of Solutol HS 15 was found to be 15 micromol/ml. Alkali fatty acids markedly improved the physical stability of the emulsions. Improved stability properties conferred to emulsions by alkali fatty acids could be attributed to the zeta potential increase even in the presence of Solutol HS 15. Consequently a mixed emulsifier film was established in which the ionized fatty acids determined the interface charge. In addition to this a strengthening of the molecular interactions occurring between phospholipid and Solutol HS 15 emulsifier in the presence of ionized fatty acids at the O/W interface can be assumed (L. Rydhag, The importance of the phase behaviour of phospholipids for emulsion stability, Fette Seifen Anstrichm. 81 (1979) 168-173). Different co-emulsifier mixtures were shown to have a pronounced impact on the plasma protein adsorption onto emulsion droplets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704897     DOI: 10.1016/s0939-6411(99)00081-8

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice.

Authors:  Manuela Pereira de Oliveira; Emmanuel Garcion; Nicolas Venisse; Jean-Pierre Benoit; William Couet; Jean-Christophe Olivier
Journal:  Pharm Res       Date:  2005-11       Impact factor: 4.200

2.  Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery.

Authors:  Tsong-Long Hwang; Chia-Lang Fang; Chao-Huang Chen; Jia-You Fang
Journal:  Pharm Res       Date:  2009-08-04       Impact factor: 4.200

3.  Date Palm Extract (Phoenix dactylifera) PEGylated Nanoemulsion: Development, Optimization and Cytotoxicity Evaluation.

Authors:  Hany Ezzat Khalil; Nashi K Alqahtani; Hossam M Darrag; Hairul-Islam Mohamed Ibrahim; Promise M Emeka; Lorina I Badger-Emeka; Katsuyoshi Matsunami; Tamer M Shehata; Heba S Elsewedy
Journal:  Plants (Basel)       Date:  2021-04-09

4.  A Novel Submicron Emulsion System Loaded with Doxorubicin Overcome Multi-Drug Resistance in MCF-7/ADR Cells.

Authors:  W P Zhou; H Y Hua; P C Sun; Y X Zhao
Journal:  Indian J Pharm Sci       Date:  2015 Jul-Aug       Impact factor: 0.975

5.  Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection.

Authors:  Chun-Yuan Cheng; Lassina Barro; Shang-Ting Tsai; Tai-Wei Feng; Xiao-Yu Wu; Che-Wei Chao; Ruei-Siang Yu; Ting-Yu Chin; Ming Fa Hsieh
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.